- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02219126
Effect of Homogenization and Pasteurization of Milk on the Stomach Problems in Adults
January 12, 2018 updated by: Kaisa Linderborg, University of Turku
This study aims to investigate differences in digestion rates and stomach problems caused by pasteurized and homogenized milk compared with raw milk in healthy adults by ingestible capsule that measures pH and pressure, diary of symptoms, blood glucose and triacylglycerol levels and plasma cytokine levels.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Turku, Finland, 20014
- Department of Biochemistry University of Turku
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Homogenized and pasteurized milk causes stomach problems (self-reported)
- unhomogenized and unpasteurized milk does not cause stomach problems (self-reported)
- age 18-65
- BMI 18,5 - 30
- hemoglobin under normal range
- fasting plasma alanine aminotransferase ALAT < 60 U/l (normal liver function)
- fasting plasma thyroid-stimulating hormone (TSH) 0.4 - 4.5 mU/l (normal thyroid function)
- fasting plasma creatinine < 118 umol/l (normal kidney function)
Exclusion Criteria:
- pace maker
- Crohn's disease or other disease of the intestinal tract
- intestinal operation within the last 3 months
- difficult dysphagia
- smoking
- constipation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Homogenized and pasteurized milk
Milk that has undergone homogenization ans pasteurization treatment
|
|
|
Experimental: Nonhomogenized and nonpasteurized milk
Unhomogenized and unpasteurized milk (raw milk)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure in the intestinal tract
Time Frame: Day 0 - Day 5
|
Pressure in the intestinal tract as measured by ingestible Smart Pill -capsule.
|
Day 0 - Day 5
|
|
Gastrointestinal symptoms (self-reported)
Time Frame: Day 0 - Day 5
|
Gastrointestinal symptoms (self-reported) as measured by a questionnaire.
The questionnaire is devided into seven types of stomach discomfort, and also includes a possibility to describe a stomach discomfort outside these seven given alternatives.
The severity of the symptoms is self-reported on a three-step scale.
|
Day 0 - Day 5
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Plasma triacylglycerols
Time Frame: 20min, 40min, 60min, 120min, 180min, 240min
|
20min, 40min, 60min, 120min, 180min, 240min
|
|
Plasma glucose
Time Frame: 20min, 40min, 60min, 90min, 120min, 180min, 240min
|
20min, 40min, 60min, 90min, 120min, 180min, 240min
|
|
Plasma triacylglycerols
Time Frame: 20min, 40min, 60min, 90min, 120min, 180min, 240min
|
20min, 40min, 60min, 90min, 120min, 180min, 240min
|
|
Plasma insulin
Time Frame: 20min, 40min, 60min, 90min, 120min, 180min, 240min
|
20min, 40min, 60min, 90min, 120min, 180min, 240min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kaisa M Linderborg, PhD, University of Turku
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2014
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
January 1, 2018
Study Registration Dates
First Submitted
August 14, 2014
First Submitted That Met QC Criteria
August 14, 2014
First Posted (Estimate)
August 18, 2014
Study Record Updates
Last Update Posted (Actual)
January 16, 2018
Last Update Submitted That Met QC Criteria
January 12, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- MILK
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Unidentified Stomach Discomfort Following Dairy Consumption
-
University of TurkuCompletedUnidentified Gastrointestinal Discomfort Following Dairy ConsumptionFinland
-
University of TurkuCompletedUnidentified Gastrointestinal Symptoms Following Pulses ConsumptionFinland
-
University of TurkuCompletedUnidentified Gastrointestinal Symptoms Following Gluten-free Oats ConsumptionFinland
-
University of TurkuCompletedUnidentified Gastrointestinal Symptoms Following Gluten-free Oats ConsumptionFinland
Clinical Trials on Dietary intervention
-
University of ViennaCompletedEndotoxemia | Dietary HabitsAustria
-
Azienda Ospedaliero-Universitaria CareggiRecruiting
-
Brown UniversityNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Brown UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
University Hospital, Strasbourg, FranceRecruitingDigestive Cancer | UndernourishedFrance
-
Josephine Ford Cancer CenterNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of South CarolinaAcademy of Nutrition and DieteticsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Terminated